Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
A startup called Catabasis is developing drugs that hit diseases at multiple targets.
Presage’s device would allow oncologists to test potentially harmful compounds in tiny amounts before giving patients a full dose.
By analyzing tumors, Foundation Medicine helps oncologists, pharma companies, and researchers combat the disease.
A startup is banking on new software that incorporates the energy of water molecules into chemical models.
A new startup, funded with $40 million from Third Rock Ventures, will develop drugs aimed at molecularly defined cancers.
The treatment suggests that the approach could be used to treat more common disorders.
A chemical that alters chemical signaling seems to ease anxiety and other symptoms.
Researchers call the experimental drug a major success for targeted cancer therapies.